InduPro, Inc.

InduPro, Inc.
Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
About
What does InduPro, Inc. do?
InduPro, Inc. is a biotechnology company that develops novel therapeutics for cancer and autoimmune diseases by defining and harnessing inherent and induced proximity biology. Their proprietary platforms, Membrane Interactomics (MInt) and Proximity Modalities (ARRIS), utilize AI and machine learning to map cell-surface protein spatial relationships, enabling the discovery of selective co-target pairs for precision drug development. The company's pipeline includes bispecific antibodies, multispec…
Is InduPro, Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for InduPro, Inc. is 61 out of 100, based on site security posture and privacy practices.
What is InduPro, Inc.'s revenue?
StartupHub estimates InduPro, Inc.'s annual revenue at $10.3M (range $2.5M to $36.6M, 35% confidence), based on comparable companies in the sector.
What is InduPro, Inc.'s valuation?
StartupHub estimates InduPro, Inc.'s effective valuation at $291.1M (range $192.5M to $462.0M, 24% confidence), based on comparable companies in the sector.
How much funding has InduPro, Inc. raised?
InduPro, Inc. has raised a total of $77M in funding. The most recent round on record is Series B.
Where is InduPro, Inc. headquartered?
InduPro, Inc. is headquartered in Seattle, United States.
When was InduPro, Inc. founded?
InduPro, Inc. was founded in 2022.
What industry does InduPro, Inc. operate in?
InduPro, Inc. operates in Biotechnology, Pharmaceuticals, HealthTech, Drug Discovery, Biotech, Genomics.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.